RAC 0.00% $1.61 race oncology ltd

RAC - $3m buy-in from prominent Biotech Investors

  1. 983 Posts.
    lightbulb Created with Sketch. 2527
    I re-read Dr Tillett’s @RaceOncology (RAC Director & Chief Scientific Officer) detailed explanation on the rationale and background behind today’s $3m share placement by strategic biotech investors.

    Now I am more confident and excited for RAC’s future then ever before ... and I have a feeling we don’t have to wait too long.

    Although I am a very large holder, even topped up today.

    https://hotcopper.com.au/data/attachments/2296/2296417-eb06a063c8d20c9785d6f1c09dda7ad5.jpg


    https://hotcopper.com.au/data/attachments/2296/2296419-c7a400792ba9e0d6f3fd8a5d235e08da.jpg
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.61
Change
0.000(0.00%)
Mkt cap ! $279.4M
Open High Low Value Volume
$1.61 $1.66 $1.61 $193.1K 118.4K

Buyers (Bids)

No. Vol. Price($)
1 1749 $1.61
 

Sellers (Offers)

Price($) Vol. No.
$1.62 1902 2
View Market Depth
Last trade - 12.55pm 29/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.